Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 4441 AL 4455

Challenges in PD Patient Management After DBS: A Pragmatic Review

Rossi M, Bruno V, Arena J, Cammarota Á, Merello M.

Mov Disord Clin Pract. 2018 Feb 28;5(3):246-254. doi: 10.1002/mdc3.12592. eCollection 2018 May-Jun.

Vastly Different Exercise Programs Similarly Improve Parkinsonian Symptoms: A Randomized Clinical Trial

Tollár J, Nagy F, Hortobágyi T.

Gerontology. 2019;65(2):120-127. doi: 10.1159/000493127. Epub 2018 Oct 26.

Drosophila Models of Sporadic Parkinson's Disease

Nagoshi E.

Int J Mol Sci. 2018 Oct 26;19(11):3343. doi: 10.3390/ijms19113343.

Chlorpromazine versus piperacetazine for schizophrenia

Eslami Shahrbabaki M, Dehnavieh R, Vali L, Sharafkhani R.

Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD011709. doi: 10.1002/14651858.CD011709.pub2.

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications

Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D.

Mov Disord. 2018 Nov;33(11):1769-1776. doi: 10.1002/mds.27488. Epub 2018 Nov 2.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

Can the gut be the missing piece in uncovering PD pathogenesis?

Chapelet G, Leclair-Visonneau L, Clairembault T, Neunlist M, Derkinderen P.

Parkinsonism Relat Disord. 2019 Feb;59:26-31. doi: 10.1016/j.parkreldis.2018.11.014. Epub 2018 Nov 12.

Parkinson's disease: Evolution of the scientific literature from 1983 to 2017 by countries and journals

Robert C, Wilson CS, Lipton RB, Arreto CD.

Parkinsonism Relat Disord. 2019 Apr;61:10-18. doi: 10.1016/j.parkreldis.2018.11.011. Epub 2018 Nov 10.

Pharmacological treatment of apathy in Lewy body disorders: A systematic review

Liu J, Cooper CA, Weintraub D, Dahodwala N.

Parkinsonism Relat Disord. 2019 Mar;60:14-24. doi: 10.1016/j.parkreldis.2018.11.002. Epub 2018 Nov 5.

Transcranial B-Mode Sonography in Movement Disorders

Yilmaz R, Berg D.

Int Rev Neurobiol. 2018;143:179-212. doi: 10.1016/bs.irn.2018.10.008. Epub 2018 Nov 13.

The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors

Pajarillo E, Rizor A, Lee J, Aschner M, Lee E.

Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):1992-2000. doi: 10.1016/j.bbadis.2018.11.017. Epub 2018 Nov 24.

Serum soluble lymphocyte activation gene-3 as a diagnostic biomarker in Parkinson's disease: A pilot multicenter study

Cui SS, Du JJ, Liu SH, Meng J, Lin YQ, Li G, He YX, Zhang PC, Chen S, Wang G.

Mov Disord. 2019 Jan;34(1):138-141. doi: 10.1002/mds.27569. Epub 2018 Nov 28.

Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism

Koens LH, Tijssen MAJ, Lange F, Wolffenbuttel BHR, Rufa A, Zee DS, de Koning TJ.

Mov Disord. 2018 Dec;33(12):1844-1856. doi: 10.1002/mds.27484. Epub 2018 Nov 28.

Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations

Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018 Sep-Oct.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias